Introducing Dante Labs Business: A B2B Portal for Advanced Genetics Dedicated to Healthcare Professionals and Researchers

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LONDON, May 28, 2019 /PRNewswire/ — Dante Labs today announced the launch of Dante Labs Business for Healthcare Professionals and Researchers (http://b2b.dantelabs.com), a new portal that combines advanced analytics, access to newest technologies and genetics expertise that thousands of individuals have come to know and love from Dante Labs, with new features and exclusive services tailored for healthcare professionals and researchers.

Dante Labs B2B customers will find tests and reports for their needs, special business-only pricing and billing. New services will be launched in the coming months, which leverage the power of sequencing in the research and healthcare space.

Some of the tests available to healthcare professionals and researchers include:

  • Pharmacogenomic Tests
  • ACMG Panels
  • Immunology Panels
  • Long Read Whole Genome Sequencing

Customers have access to volume discounts, with different tiers.

“Private clinics and researchers have come to value the services and technical support of Dante Labs,” said Andrea Riposati, CEO of Dante Labs. “We have heard their requests for a more tailored online buying experience and for additional services that cannot be offered to individuals. We aim at bringing advanced genetics to all the researches and healthcare professionals that can’t afford to purchase and run their own sequencing equipment and create their own reporting pipelines.”

New customers must request access to the Dante Labs B2B Portal by registering on the website (http://b2b.dantelabs.com). Only accredited clinics, doctors, healthcare professionals and researchers will be granted access.

To apply for a free Dante Labs B2B account, please visit b2b.dantelabs.com.

Media Contact: 
Francesco Pennelli
Phone: +39-3206-030072
Email: francesco@dantelabs.com

Related Files

Dante Labs – Sample_Pharmacogenetics_Report.pdf

Dante Labs – Sample_Comprehensive_Epilepsy_Panel_Positive.pdf

Related Images

image1.png
image2.jpg

dante-labs-ceo-andrea-riposati.jpg
Dante Labs CEO Andrea Riposati

Related Links

Dante Labs Business

Dante Labs

View original content to download multimedia:http://www.prnewswire.com/news-releases/introducing-dante-labs-business-a-b2b-portal-for-advanced-genetics-dedicated-to-healthcare-professionals-and-researchers-300857542.html

SOURCE Dante Labs

Staff

Recent Posts

ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer

Most Recently Serving as President for Oticon, a Division of Demant, Rosenblum Brings 30+ Years…

8 seconds ago

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a company working to improve outcomes for…

3 hours ago

As Dangerous US Heat Wave Intensifies, AccuWeather Urges Public to Rely on Science-Backed RealFeel® Temperature for Accurate Danger Index

AccuWeather's RealFeel® Temperature is the only authentic formula-based metric—unlike 'Feels Like,' which lacks scientific credibility.Request…

3 hours ago

New Data Signals IVD Growth in a Shifting Market Amid Tariff Uncertainty

Kalorama Identifies Point-of-Care Testing Momentum and Strategic Blind Spots in Latest Diagnostic Trends Analysis ARLINGTON,…

3 hours ago

Medmovie Hx Heart App Launch Elevates Health Literacy and Empowers Shared Decision Making for Cardiovascular Care

Digital tool equips healthcare providers with trusted visual content to simplify complex heart information at…

3 hours ago

Premera Blue Cross Blue Shield of Alaska Announces Actions to Simplify Prior Authorization Process

Blue Cross and Blue Shield companies aim to improve the prior authorization process to make…

3 hours ago